Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 124

1.

Effect of tiotropium on COPD exacerbations: A systematic review.

Halpin DM, Vogelmeier C, Pieper MP, Metzdorf N, Richard F, Anzueto A.

Respir Med. 2016 May;114:1-8. doi: 10.1016/j.rmed.2016.02.012. Epub 2016 Mar 2. Review.

2.

Case finding for chronic obstructive pulmonary disease in people attending long-term condition clinics in primary care.

Halpin D, Holmes S, Calvert J, McInerney D.

Chron Respir Dis. 2016 Apr 12. pii: 1479972316643011. [Epub ahead of print]

PMID:
27072019
3.

Diagnosis, assessment, and phenotyping of COPD: beyond FEV1.

Lange P, Halpin DM, O'Donnell DE, MacNee W.

Int J Chron Obstruct Pulmon Dis. 2016 Feb 19;11 Spec Iss:3-12. doi: 10.2147/COPD.S85976. eCollection 2016. Review.

4.

A review of national guidelines for management of COPD in Europe.

Miravitlles M, Vogelmeier C, Roche N, Halpin D, Cardoso J, Chuchalin AG, Kankaanranta H, Sandström T, Śliwiński P, Zatloukal J, Blasi F.

Eur Respir J. 2016 Feb;47(2):625-37. doi: 10.1183/13993003.01170-2015. Epub 2016 Jan 21.

5.

Understanding fear and anxiety in patients at the time of an exacerbation of chronic obstructive pulmonary disease: a qualitative study.

Halpin D, Hyland M, Blake S, Seamark C, Pinnuck M, Ward D, Whalley B, Greaves C, Hawkins A, Seamark D.

JRSM Open. 2015 Nov 18;6(12):2054270415614543. doi: 10.1177/2054270415614543. eCollection 2015 Dec.

6.

The Effect of Tiotropium in Symptomatic Asthma Despite Low- to Medium-Dose Inhaled Corticosteroids: A Randomized Controlled Trial.

Paggiaro P, Halpin DM, Buhl R, Engel M, Zubek VB, Blahova Z, Moroni-Zentgraf P, Pizzichini E.

J Allergy Clin Immunol Pract. 2016 Jan-Feb;4(1):104-13.e2. doi: 10.1016/j.jaip.2015.08.017. Epub 2015 Nov 7.

7.

The Effect of Incidental Consolidation on Management and Outcomes in COPD Exacerbations: Data from the European COPD Audit.

Saleh A, López-Campos JL, Hartl S, Pozo-Rodríguez F, Roberts CM; European COPD Audit team.

PLoS One. 2015 Jul 27;10(7):e0134004. doi: 10.1371/journal.pone.0134004. eCollection 2015.

8.

Tiotropium HandiHaler(®) and Respimat(®) in COPD: a pooled safety analysis.

Halpin DM, Dahl R, Hallmann C, Mueller A, Tashkin D.

Int J Chron Obstruct Pulmon Dis. 2015 Feb 5;10:239-59. doi: 10.2147/COPD.S75146. eCollection 2015.

9.

Investigating Women's Experiences of Asthma Care in Pregnancy: A Qualitative Study.

Chamberlain C, Williamson GR, Knight B, Daly M, Halpin DM.

Open Nurs J. 2014 Dec 11;8:56-63. doi: 10.2174/1874434601408010056. eCollection 2014.

10.

A retrospective study of the impact of a telephone alert service (Healthy Outlook) on hospital admissions for patients with chronic obstructive pulmonary disease.

Sarran C, Halpin D, Levy ML, Prigmore S, Sachon P.

NPJ Prim Care Respir Med. 2014 Oct 23;24:14080. doi: 10.1038/npjpcrm.2014.80.

11.

The WISDOM of inhaled corticosteroids in COPD.

Halpin DM, Quint JK.

Thorax. 2014 Dec;69(12):1071-2. doi: 10.1136/thoraxjnl-2014-206333. Epub 2014 Oct 16. No abstract available.

PMID:
25323619
12.

Acute bronchodilator responses decline progressively over 4 years in patients with moderate to very severe COPD.

Tashkin DP, Li N, Kleerup EC, Halpin D, Celli B, Decramer M, Elashoff R.

Respir Res. 2014 Aug 31;15:102. doi: 10.1186/s12931-014-0102-5.

13.

Opportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohort.

Jones RC, Price D, Ryan D, Sims EJ, von Ziegenweidt J, Mascarenhas L, Burden A, Halpin DM, Winter R, Hill S, Kearney M, Holton K, Moger A, Freeman D, Chisholm A, Bateman ED; Respiratory Effectiveness Group.

Lancet Respir Med. 2014 Apr;2(4):267-76. doi: 10.1016/S2213-2600(14)70008-6. Epub 2014 Feb 13.

14.

Tiotropium Respimat inhaler and the risk of death in COPD.

Wise RA, Anzueto A, Cotton D, Dahl R, Devins T, Disse B, Dusser D, Joseph E, Kattenbeck S, Koenen-Bergmann M, Pledger G, Calverley P; TIOSPIR Investigators.

N Engl J Med. 2013 Oct 17;369(16):1491-501. doi: 10.1056/NEJMoa1303342. Epub 2013 Aug 30.

15.

Annual rates of change in pre- vs. post-bronchodilator FEV1 and FVC over 4 years in moderate to very severe COPD.

Tashkin DP, Li N, Halpin D, Kleerup E, Decramer M, Celli B, Elashoff R.

Respir Med. 2013 Dec;107(12):1904-11. doi: 10.1016/j.rmed.2013.08.001. Epub 2013 Aug 22.

16.

The reply.

Halpin DJ, Rencic JJ.

Am J Med. 2013 May;126(5):e17. doi: 10.1016/j.amjmed.2013.01.014. No abstract available.

PMID:
23582942
17.

Exacerbation frequency and course of COPD.

Halpin DM, Decramer M, Celli B, Kesten S, Liu D, Tashkin DP.

Int J Chron Obstruct Pulmon Dis. 2012;7:653-61. doi: 10.2147/COPD.S34186. Epub 2012 Sep 21.

19.

"You get old, you get breathless, and you die": chronic obstructive pulmonary disease in Barnsley, UK.

Small N, Gardiner C, Barnes S, Gott M, Halpin D, Payne S, Seamark D.

Health Place. 2012 Nov;18(6):1396-403. doi: 10.1016/j.healthplace.2012.07.004. Epub 2012 Aug 11.

PMID:
22889997
20.

A real exercise stress test.

Halpin DJ, Rencic JJ.

Am J Med. 2012 Aug;125(8):761-3. doi: 10.1016/j.amjmed.2012.06.003. No abstract available.

PMID:
22840663
Items per page

Supplemental Content

Loading ...
Write to the Help Desk